English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90429/105609 (86%)
Visitors : 10344146      Online Users : 317
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/25453


    Title: Impact of dialysis modality on the survival of end-stage renal disease patients with or without cardiovascular disease
    Authors: 王怡寬;Wang, I-Kuan;龔佩珍;Kung, Pei-Tseng;郭娓吟;Kuo, Wei-Yin;蔡文正;Tsai, Wen-Chen;Chan, Yi-Chih;Chang, Yi-Chih;Li, Chih-Chia;Liang, Chih-Chia;Chiz-Tzung, C;Chang, Chiz-Tzung;Hung-Chieh, Y;Yeh, Hung-Chieh;Shu-Ming Wang,;Feng-Rong Chuang,;Wan, Kwua-Yun;Wang, Kwua-Yun;Ching-Yuang;Lin, Ching-Yuang;Chiu-Ching, H;Huang, Chiu-Ching
    Contributors: 健康產業管理學系
    Keywords: Diabetes;Dialysis;Congestive heart failure;Coronary artery disease;Survival
    Date: 2013-03
    Issue Date: 2013-07-11 14:25:30 (UTC+8)
    Abstract: BACKGROUND: The question of which modality, either peritoneal dialysis (PD) or hemodialysis (HD), confers the survival advantage for incident ESRD patients with pre-existing cardiovascular disease (CVD) remains unanswered.

    METHODS: Data used in this study were extracted from the National Health Insurance Research Database in Taiwan. From 1997 to 2007, incident ESRD patients who underwent dialysis longer than three months were selected. The established dialysis modality at day 90 was used to analyze the impact of dialysis modality on survival. For each PD patient indentified, five HD patients matched for age, sex, and year in which the patients received their first dialysis treatment were randomly selected. Finally, a total of 35 664 patients including 29 720 HD patients and 5944 PD patients were selected. The primary outcome was death after commencing dialysis.

    RESULTS: For diabetic ESRD patients with or without coronary artery disease (CAD) or congestive heart failure (CHF), patients receiving PD had inferior survival compared with those receiving HD (P<.001, adjusted HR=1.34 to 1.43). For nondiabetic patients with CAD or CHF, patients receiving PD also had inferior survival compared with those receiving HD (adjusted HR=1.30, CI: 1.08 to 1.57; adjusted HR=1.31, CI: 1.11 to 1.55). For nondiabetic ESRD patients without CAD or CHF, there was no statistically significant difference in survival between PD and HD (adjusted HR=1.00, CI: 0.92 to 1.09; adjusted HR=0.98, CI: 0.90 to 1.07).
    CONCLUSIONS: PD was associated with poorer survival among ESRD patients with CVD or diabetes mellitus compared with HD.
    BACKGROUND:
    The question of which modality, either peritoneal dialysis (PD) or hemodialysis (HD), confers the survival advantage for incident ESRD patients with pre-existing cardiovascular disease (CVD) remains unanswered.
    METHODS:
    Data used in this study were extracted from the National Health Insurance Research Database in Taiwan. From 1997 to 2007, incident ESRD patients who underwent dialysis longer than three months were selected. The established dialysis modality at day 90 was used to analyze the impact of dialysis modality on survival. For each PD patient indentified, five HD patients matched for age, sex, and year in which the patients received their first dialysis treatment were randomly selected. Finally, a total of 35 664 patients including 29 720 HD patients and 5944 PD patients were selected. The primary outcome was death after commencing dialysis.
    RESULTS:
    For diabetic ESRD patients with or without coronary artery disease (CAD) or congestive heart failure (CHF), patients receiving PD had inferior survival compared with those receiving HD (P<.001, adjusted HR=1.34 to 1.43). For nondiabetic patients with CAD or CHF, patients receiving PD also had inferior survival compared with those receiving HD (adjusted HR=1.30, CI: 1.08 to 1.57; adjusted HR=1.31, CI: 1.11 to 1.55). For nondiabetic ESRD patients without CAD or CHF, there was no statistically significant difference in survival between PD and HD (adjusted HR=1.00, CI: 0.92 to 1.09; adjusted HR=0.98, CI: 0.90 to 1.07).
    CONCLUSIONS:
    PD was associated with poorer survival among ESRD patients with CVD or diabetes mellitus compared with HD.
    Relation: JOURNAL OF NEPHROLOGY,26(2):331-341.
    Appears in Collections:[健康產業管理學系] 期刊論文

    Files in This Item:

    File SizeFormat
    index.html0KbHTML281View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback